– the leading provider of online annual reports to individual and institutional investors.

Generex Biotechnology Corp.

Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the oral administration of large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports